OSE Immunotherapeutics
OSE.PA
#10411
Rank
C$56.83 M
Marketcap
C$2.22
Share price
-7.17%
Change (1 day)
-74.51%
Change (1 year)

Earnings for OSE Immunotherapeutics (OSE.PA)

Earnings in 2025: -C$63.03 Million

According to OSE Immunotherapeutics's latest financial reports the company's current earnings are C$3.07 Million. In 2025 the company made an earning of -C$63.03 Million a decrease over its 2024 earnings that were of C$59.43 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for OSE Immunotherapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025-C$63.03 Million-206.04%
2024C$59.43 M-261.47%
2023-C$36.82 Million32.79%
2022-C$27.73 Million-0.83%
2021-C$27.96 Million-17.65%
2020-C$33.95 Million1343.42%
2019-C$2.36 Million-130.46%
2018C$7.72 M-135.22%
2017-C$21.93 Million-182.62%
2016C$26.53 M-403.67%
2015-C$8.74 Million76.85%
2014-C$4.95 Million897.97%
2013-C$0.5 Million-81.82%
2012-C$2.73 Million